Intratio
Loading...
Skip to main content
Model output · Signal date 2026-11-06

Agilon Health, Inc. (AGL) Stock Forecast Nov. 6, 2026

Analysis updated on Nov. 6, 2026 (UTC) · Alpha · vs marketSwitch to Total · NYSE

Share
X LinkedIn Reddit WhatsApp Telegram
Embed badge
Unlock full AI forecasts
Rating · 90D Unlock rating and forecasts
90-day forecast Sign up free to reveal
30-day forecast Alpha
Rank in coverage of 5150 stocks scored
Rank correlation · 90D 42.0% Spearman, 357 dates
Market Cap $1.90B small-cap · #5 of 13 peers
Summary

Agilon Health, Inc. (AGL) stock forecast summary

Our AI scores Agilon Health, Inc. every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.

Agilon Health, Inc. is a small-cap company with a market capitalization of $1.90B. It ranks number 5 by market capitalization among the 13 Services-Misc Health & Allied Services, NEC issuers in our coverage with a current forecast. Its P/B Ratio of 6.78x is the highest of the 9 peers that report one.

For AGL, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 42.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 36.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +3.1%, buy ≥ +1.5%, sell < -0.5%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-11-06 signals)

A free account shows the exact forecast, rating and rank of 3 tickers you follow, AGL included.

Price

AGL price chart and AI forecast

AGL
Cross-section · 2026-11-06

How AGL ranks among 5150 stocks

90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

Fundamentals · 2026-09-30

Agilon Health, Inc. (AGL) fundamentals

Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Services-Misc Health & Allied Services, NEC peers listed below that report each metric.

Valuation & Market

MetricAGLIndustry medianRank
Market Cap $1.90B $96M 5/13
P/B Ratio 6.78x 2.32x 1/9
EPS $-5.55 – –
Book Value/Share $16.73 – –
Revenue/Share $357.58 – –
FCF/Share $-1.01 – –

Profitability & Margins

MetricAGLIndustry medianRank
ROE -31.0% 9.1% 5/6
ROA -5.6% 1.0% 6/8
ROIC -46.3% 10.2% 7/8
Operating Margin -2.6% 0.6% 6/9
Net Margin -1.4% 4.8% 6/9
EBT Margin -1.7% 2.8% 6/10
Tax Rate -4.8% – –

Financial Health

MetricAGLIndustry medianRank
Current Ratio 1.13x 1.25x 7/11
D/E Ratio 4.57x 0.58x 2/10
Financial Leverage 5.57x 1.53x 2/9
Interest Coverage 19.5x 4.9x 4/12
Working Capital $166M $12M 4/11

Cash Flow

MetricAGLIndustry medianRank
Operating Cash Flow -$4M $3M 8/10
Free Cash Flow -$17M $21M 7/7
Capital Spending -$13M -$28M 3/7
FCF/Sales -0.3% 11.0% 7/7
CapEx/Sales 0.2% 2.1% 7/7

Operational Efficiency

MetricAGLIndustry medianRank
Asset Turnover 3.84x 0.80x 1/9
Receivables Turnover 5.9x 5.9x 5/9
Fixed Assets Turnover 249.8x 4.7x 1/8
Days Sales Outstanding 62 days 62 days 5/9

Income Statement

MetricAGLIndustry medianRank
Total Revenue $6.00B $770M 3/10
Operating Income -$154M $190K 9/9
Net Income -$87M $1M 9/9

Dividend & Shareholder Information

MetricAGLIndustry medianRank
Shares Outstanding 17M – –

Balance Sheet Highlights (USD millions)

Total Current Assets$1.40B89.4% of assets
Cash & Short-term Investments$174M11.1% of assets
Accounts Receivable$1.02B65.0% of assets
Total Liabilities$1.28B82.1% of assets
Quarterly Financial Reports

AGL quarterly financials and insider trading

Industry Peers · Services-Misc Health & Allied Services, NEC

Agilon Health, Inc. (AGL) industry peers

Companies classified under the same SEC industry code as Agilon Health, Inc. (Services-Misc Health & Allied Services, NEC): 13 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.

Reveal all forecasts · See exact % predictions for all competitors

Sign up free
Company 90-Day AI Forecast (Alpha) Market Cap P/E Ratio P/B Ratio
AGL Agilon Health, Inc. $1.90B – 6.8x
FMS Fresenius Medical Care Ag $12.15B – –
DVA Davita Inc. $12.04B 14.2x –
SHC Sotera Health Co $4.53B 52.9x 6.2x
PGNY Progyny, Inc. $2.64B 41.9x 6.4x
VMD Viemed Healthcare, Inc. $348M 23.4x 2.3x
PARK Park Dental Partners, Inc. $96M – 3.2x
MRAI Marpai, Inc. $74M – –
CCEL Cryo Cell International Inc $40M – –
PFHO Pacific Health Care Organization Inc $13M 8.3x 0.9x
NIVF Newgenivf Group Ltd $5M – 0.2x
MGRX Mangoceuticals, Inc. $4M – 0.3x
BRTX Biorestorative Therapies, Inc. $2M – 0.6x

Where AGL sits on the market map

Industrial Applications and Services · Services-Misc Health & Allied Services, NEC
Explore the map →
News

Agilon Health, Inc. (AGL) stock news

source: Seeking Alpha

Hello, and welcome to the agilon health Fourth Quarter 2025 Earnings Conference Call. My name is Carla, and I will be coordinating your call today. Thank you, operator. Good afternoon, and welcome to ...

More news available

Sign up free to read all 12 news articles and stay updated on market developments.

Sign Up Free to Read More
FAQ

Agilon Health, Inc. (AGL) stock forecast FAQ

What is the Agilon Health, Inc. (AGL) stock forecast?

Our AI scores Agilon Health, Inc. every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.

How accurate are Agilon Health, Inc. stock predictions?

For AGL, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 42.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 36.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

How often are Agilon Health, Inc. forecasts updated?

Agilon Health, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Nov. 6, 2026.

Which companies are Agilon Health, Inc.'s industry peers?

13 issuers in our coverage, AGL included, share the SEC industry code Services-Misc Health & Allied Services, NEC. The largest are: Fresenius Medical Care Ag (FMS), Davita Inc. (DVA), Sotera Health Co (SHC), Progyny, Inc. (PGNY), Viemed Healthcare, Inc. (VMD), Park Dental Partners, Inc. (PARK).

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.